skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 4
Patent #:
Issue Dt:
11/17/1987
Application #:
06818848
Filing Dt:
01/14/1986
Inventors:
MICHAEL KOLB, DAVID A. KENDRICK
Title:
FLUORINATED DIAMINOALKYNE DERIVATIVES
Assignment: 1
Reel/Frame:
004639/0126Recorded: 12/02/1986Pages: 2
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST.
Assignor:
Exec Dt:
01/21/1986
Assignee:
2110 EAST GALBRAITH ROAD P.O. BOX 156 300
A CORP. OF DE.
CINCINNATI, OHIO 45215-6300
Correspondent:
MERRELL DOW PHARMACEUTICALS, INC.
2110 E. GALBRAITH ROAD
CINCINNATI, OHIO 45215
Assignment: 2
Reel/Frame:
004639/0128Recorded: 12/02/1986Pages: 1
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST.
Assignors:
Exec Dt:
01/21/1986
Exec Dt:
01/21/1986
Assignee:
Correspondent:
MERRELL DOW PHARMACEUTICALS, INC.
PATENT DEPT.
2110 E. GALBRAITH ROAD
CINCINNATI, OHIO 4521-50000
Assignment: 3
Reel/Frame:
004639/0128Recorded: 12/02/1986Pages: 1
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST.
Assignors:
Exec Dt:
01/21/1986
Exec Dt:
01/21/1986
Assignee:
Correspondent:
MERRELL DOW PHARMACEUTICALS, INC.
PATENT DEPT.
2110 E. GALBRAITH ROAD
CINCINNATI, OHIO 4521-50000
Assignment: 4
Reel/Frame:
016522/0001Recorded: 09/12/2005Pages: 9
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
09/15/1995
Assignee:
300 SOMERSET CORPORATE BLVD.
BRIDGEWATER, NEW JERSEY 08807-2854
Correspondent:
ROSS J. OEHLER
ROUTE #202-206/P.O. BOX 6800
MAIL CODE: D303-A
BRIDGEWATER, NJ 08807

Search Results as of: 05/30/2024 01:26 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT